4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingNot applicable2026-08-26NCT07227831
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic CancerMetastatic Pancreatic AdenocarcinomaRecruitingPhase 22026-08-10NCT06576115
TheraBionic P1 Device in Subjects With Advanced Hepatocellular CarcinomaHepatocellular Carcinoma RecurrentRecruitingNot applicable2026-04-13NCT07118202
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal CancerMetastatic Colorectal AdenocarcinomaRecruitingPhase 22025-11-10NCT07130903